GlaxoSmithkline Consumer Healthcare (Delisted) share news and announcements
BSE: 500676
Last traded ₹10,732.60 on 15 Apr 2020
Delisted on 24 Jun 2021.
GlaxoSmithkline Consumer Healthcare share news and announcements
668 announcements, routine notices left out, newest first. Page 5 of 14.
May 2018
Apr 2018
24 Apr · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
24 Apr · Certificate In Terms Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
20 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 14 14 <td class='TTRow'19 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....
Mar 2018
28 Mar · Board meeting
27 Mar · Strategic Review Of Horlicks And Other Consumer Nutrition Products
20 Mar · Board meeting
20 Mar · Meeting Of The Board Of Directors Of The Company To Be Held On March 28, 2018
Feb 2018
Jan 2018
19 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
Dec 2017
8 Dec · Legal
Exchange had sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to announcement dated 06-Dec-2017, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is as follow- Mr Navneet Saluja has completed his MBA from Jamnalal Bajaj Institute of Management in 1987. Mr Navneet Saluja started his career with Cadbury India as a Management Trainee. He then had a long and successful stint with Gillette India. In his last role with Gillette, Mr Navneet Saluja was the VP Sales when he successfully restructured the sales & distribution network for the company. He has also worked with Kelloggs India, as the Sales & Marketing Director, where he drove improvement in gross margins and operating profits. Mr Navneet Saluja has worked as the CEO for Reliance Retail for Delhi and Haryana Region. He also worked as the CEO for Reliance Infocom. In both the roles, he was responsible for general management of business. Mr Navneet Saluja joined GSK India in 2008, initially as the Sales Head for India. Subsequently he was appointed as the Area GM Middle East. Following consolidation with Africa earlier this year, he has successfully led the MEA area to consistently deliver strong commercial performance.7 Dec · Legal
Exchange has sought clarification from GlaxoSmithKline Consumer Healthcare Limited with respect to announcement dated 06-Dec-2017, regarding Change in Director(s) of the company.". On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment); The response of the Company is awaited.6 Dec · Management
Nov 2017
20 Nov · Management
Oct 2017
12 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....12 Oct · Certificate In Terms Of Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015
12 Oct · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations, 2015
12 Oct · Statement Of Investor Complaints Under Regulation 13 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended September 30, 2017
Sep 2017
Aug 2017
Jul 2017
13 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....